{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:08:21Z","timestamp":1789787301384,"version":"4.0.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T00:00:00Z","timestamp":1629676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T00:00:00Z","timestamp":1629676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"national natural science foundation of china","doi-asserted-by":"publisher","award":["81971651"],"award-info":[{"award-number":["81971651"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2019J01454"],"award-info":[{"award-number":["2019J01454"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2020J05249"],"award-info":[{"award-number":["2020J05249"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fujian Provincial Health Commission Science and Technology and Programme","award":["2020GGA045"],"award-info":[{"award-number":["2020GGA045"]}]},{"name":"Fujian Provincial Health and Family Planning Youth Scientific Research Project","award":["2018-2-21"],"award-info":[{"award-number":["2018-2-21"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s12149-021-01673-w","type":"journal-article","created":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T15:06:03Z","timestamp":1629731163000},"page":"1312-1320","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Characterization of the benign lesions with increased 68Ga-FAPI-04 uptake in PET\/CT"],"prefix":"10.1007","volume":"35","clinical-trial-number":[{"clinical-trial-number":"nct04499365","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Shan","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieling","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zefang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaixian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaobo","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0058-4953","authenticated-orcid":false,"given":"Weibing","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,23]]},"reference":[{"issue":"18","key":"1673_CR1","doi-asserted-by":"publisher","first-page":"7235","DOI":"10.1073\/pnas.87.18.7235","volume":"87","author":"P Garin-Chesa","year":"1990","unstructured":"Garin-Chesa P, Old LJ, Rettig WJ. Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers. Proc Natl Acad Sci USA. 1990;87(18):7235\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5\u20136","key":"1673_CR2","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/prca.201300095","volume":"8","author":"EJ Hamson","year":"2014","unstructured":"Hamson EJ, Keane FM, Tholen S, Schilling O, Gorrell MD. Understanding fibroblast activation protein (FAP): substrates, activities, expression and targeting for cancer therapy. Proteom Clin Appl. 2014;8(5\u20136):454\u201363.","journal-title":"Proteom Clin Appl"},{"issue":"14","key":"1673_CR3","first-page":"3327","volume":"53","author":"WJ Rettig","year":"1993","unstructured":"Rettig WJ, Garin-Chesa P, Healey JH, Su SL, Ozer HL, Schwab M, et al. Regulation and heteromeric structure of the fibroblast activation protein in normal and transformed cells of mesenchymal and neuroectodermal origin. Cancer Res. 1993;53(14):3327\u201335.","journal-title":"Cancer Res"},{"issue":"2\u20133","key":"1673_CR4","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1023\/A:1023055600919","volume":"22","author":"WT Chen","year":"2003","unstructured":"Chen WT, Kelly T. Seprase complexes in cellular invasiveness. Cancer Metastasis Rev. 2003;22(2\u20133):259\u201369.","journal-title":"Cancer Metastasis Rev"},{"issue":"8","key":"1673_CR5","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1158\/0008-5472.CAN-03-3184","volume":"64","author":"Y Huang","year":"2004","unstructured":"Huang Y, Wang S, Kelly T. Seprase promotes rapid tumor growth and increased microvessel density in a mouse model of human breast cancer. Cancer Res. 2004;64(8):2712\u20136.","journal-title":"Cancer Res"},{"issue":"1\u20132","key":"1673_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.drup.2005.03.002","volume":"8","author":"T Kelly","year":"2005","unstructured":"Kelly T. Fibroblast activation protein-alpha and dipeptidyl peptidase IV (CD26): cell-surface proteases that activate cell signaling and are potential targets for cancer therapy. Drug Resist Update. 2005;8(1\u20132):51\u20138.","journal-title":"Drug Resist Update"},{"issue":"14","key":"1673_CR7","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1158\/0008-5472.CAN-15-2973","volume":"76","author":"X Yang","year":"2016","unstructured":"Yang X, Lin Y, Shi Y, Li B, Liu W, Yin W, et al. FAP Promotes immunosuppression by cancer-associated fibroblasts in the tumor microenvironment via STAT3-CCL2 signaling. Cancer Res. 2016;76(14):4124\u201335.","journal-title":"Cancer Res"},{"issue":"9","key":"1673_CR8","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.2967\/jnumed.118.210443","volume":"59","author":"T Lindner","year":"2018","unstructured":"Lindner T, Loktev A, Altmann A, Giesel F, Kratochwil C, Debus J, et al. Development of quinoline-based theranostic ligands for the targeting of fibroblast activation protein. J Nucl Med. 2018;59(9):1415\u201322.","journal-title":"J Nucl Med"},{"issue":"9","key":"1673_CR9","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.2967\/jnumed.118.210435","volume":"59","author":"A Loktev","year":"2018","unstructured":"Loktev A, Lindner T, Mier W, Debus J, Altmann A, J\u00e4ger D, et al. A tumor-imaging method targeting cancer-associated fibroblasts. J Nucl Med. 2018;59(9):1423\u20139.","journal-title":"J Nucl Med"},{"issue":"3","key":"1673_CR10","doi-asserted-by":"publisher","first-page":"386","DOI":"10.2967\/jnumed.118.215913","volume":"60","author":"FL Giesel","year":"2019","unstructured":"Giesel FL, Kratochwil C, Lindner T, Marschalek MM, Loktev A, Lehnert W, et al. (68)Ga-FAPI PET\/CT: biodistribution and preliminary dosimetry estimate of 2 DOTA-containing FAP-targeting agents in patients with various cancers. J Nucl Med. 2019;60(3):386\u201392.","journal-title":"J Nucl Med"},{"issue":"6","key":"1673_CR11","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2967\/jnumed.119.227967","volume":"60","author":"C Kratochwil","year":"2019","unstructured":"Kratochwil C, Flechsig P, Lindner T, Abderrahim L, Altmann A, Mier W, et al. (68)Ga-FAPI PET\/CT: tracer uptake in 28 different kinds of cancer. J Nucl Med. 2019;60(6):801\u20135.","journal-title":"J Nucl Med"},{"issue":"12","key":"1673_CR12","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1007\/s00259-019-04444-y","volume":"46","author":"M R\u00f6hrich","year":"2019","unstructured":"R\u00f6hrich M, Loktev A, Wefers AK, Altmann A, Paech D, Adeberg S, et al. IDH-wildtype glioblastomas and grade III\/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein-specific PET\/CT. Eur J Nucl Med Mol Imaging. 2019;46(12):2569\u201380.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"1673_CR13","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1007\/s00259-020-04769-z","volume":"47","author":"H Chen","year":"2020","unstructured":"Chen H, Pang Y, Wu J, Zhao L, Hao B, Wu J, et al. Comparison of [(68)Ga]Ga-DOTA-FAPI-04 and [(18)F] FDG PET\/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer. Eur J Nucl Med Mol Imaging. 2020;47(8):1820\u201332.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"1673_CR14","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.2967\/jnumed.119.237016","volume":"61","author":"SA Koerber","year":"2020","unstructured":"Koerber SA, Staudinger F, Kratochwil C, Adeberg S, Haefner MF, Ungerechts G, et al. The role of (68)Ga-FAPI PET\/CT for patients with malignancies of the lower gastrointestinal tract: first clinical experience. J Nucl Med. 2020;61(9):1331\u20136.","journal-title":"J Nucl Med"},{"issue":"1","key":"1673_CR15","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00259-020-04940-6","volume":"48","author":"H Chen","year":"2021","unstructured":"Chen H, Zhao L, Ruan D, Pang Y, Hao B, Dai Y, et al. Usefulness of [(68)Ga]Ga-DOTA-FAPI-04 PET\/CT in patients presenting with inconclusive [(18)F]FDG PET\/CT findings. Eur J Nucl Med Mol Imaging. 2021;48(1):73\u201386.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"1673_CR16","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1007\/s00259-020-05070-9","volume":"48","author":"X Shi","year":"2021","unstructured":"Shi X, Xing H, Yang X, Li F, Yao S, Congwei J, et al. Comparison of PET imaging of activated fibroblasts and (18)F-FDG for diagnosis of primary hepatic tumours: a prospective pilot study. Eur J Nucl Med Mol Imaging. 2021;48(5):1593\u2013603.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"1673_CR17","doi-asserted-by":"publisher","first-page":"e433","DOI":"10.1097\/RLU.0000000000003594","volume":"46","author":"C G\u00fcndo\u011fan","year":"2021","unstructured":"G\u00fcndo\u011fan C, G\u00fczel Y, Can C, Alabalik U, K\u00f6mek H. False-positive 68Ga-fibroblast activation protein-specific inhibitor uptake of benign lymphoid tissue in a patient with breast cancer. Clin Nucl Med. 2021;46(8):e433\u20135.","journal-title":"Clin Nucl Med"},{"issue":"5","key":"1673_CR18","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1097\/RLU.0000000000003608","volume":"46","author":"Y Luo","year":"2021","unstructured":"Luo Y, Pan Q, Yang H, Li F, Zhang F. Inflammatory arthritis induced by anti-programmed death-1 shown in 68Ga-FAPI PET\/CT in a patient with esophageal carcinoma. Clin Nucl Med. 2021;46(5):431\u20132.","journal-title":"Clin Nucl Med"},{"issue":"6","key":"1673_CR19","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1097\/RLU.0000000000003560","volume":"46","author":"J Wu","year":"2021","unstructured":"Wu J, Liu H, Ou L, Jiang G, Zhang C. FAPI uptake in a vertebral body fracture in a patient with lung cancer: a FAPI imaging pitfall. Clin Nucl Med. 2021;46(6):520\u20132.","journal-title":"Clin Nucl Med"},{"issue":"6","key":"1673_CR20","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1007\/s00259-020-05185-z","volume":"48","author":"J Zheng","year":"2021","unstructured":"Zheng J, Chen H, Lin K, Yao S, Miao W. [(68)Ga]Ga-FAPI and [(18)F]FDG PET\/CT images in a patient with juvenile polymyositis. Eur J Nucl Med Mol Imaging. 2021;48(6):2051\u20132.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"1673_CR21","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1097\/RLU.0000000000003621","volume":"46","author":"H Liu","year":"2021","unstructured":"Liu H, Chen Z, Yang X, Fu W, Chen Y. Increased 68Ga-FAPI uptake in chronic cholecystitis and degenerative osteophyte. Clin Nucl Med. 2021;46(7):601\u20132.","journal-title":"Clin Nucl Med"},{"issue":"21","key":"1673_CR22","doi-asserted-by":"publisher","first-page":"115094","DOI":"10.1016\/j.bmc.2019.115094","volume":"27","author":"B Liu","year":"2019","unstructured":"Liu B, Zhang Z, Wang H, Yao S. Preclinical evaluation of a dual sstr2 and integrin \u03b1(v)\u03b2(3)-targeted heterodimer [(68)Ga]-NOTA-3PEG(4)-TATE-RGD. Bioorg Med Chem. 2019;27(21):115094.","journal-title":"Bioorg Med Chem"},{"issue":"4","key":"1673_CR23","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1111\/jgh.12840","volume":"30","author":"J Jia","year":"2015","unstructured":"Jia J, Hou J, Ding H, Chen G, Xie Q, Wang Y, et al. Transient elastography compared to serum markers to predict liver fibrosis in a cohort of Chinese patients with chronic hepatitis B. J Gastroenterol Hepatol. 2015;30(4):756\u201362.","journal-title":"J Gastroenterol Hepatol"},{"issue":"32","key":"1673_CR24","doi-asserted-by":"publisher","first-page":"4343","DOI":"10.1038\/s41388-018-0275-3","volume":"37","author":"E Pur\u00e9","year":"2018","unstructured":"Pur\u00e9 E, Blomberg R. Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics. Oncogene. 2018;37(32):4343\u201357.","journal-title":"Oncogene"},{"issue":"2","key":"1673_CR25","doi-asserted-by":"publisher","first-page":"266","DOI":"10.2967\/jnumed.120.244723","volume":"62","author":"Y Luo","year":"2021","unstructured":"Luo Y, Pan Q, Yang H, Peng L, Zhang W, Li F. Fibroblast activation protein-targeted PET\/CT with (68)Ga-FAPI for imaging IgG4-related disease: comparison to (18)F-FDG PET\/CT. J Nucl Med. 2021;62(2):266\u201371.","journal-title":"J Nucl Med"},{"issue":"4","key":"1673_CR26","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/RLU.0000000000002914","volume":"45","author":"Y Luo","year":"2020","unstructured":"Luo Y, Pan Q, Zhang W, Li F. Intense FAPI uptake in inflammation may mask the tumor activity of pancreatic cancer in 68Ga-FAPI PET\/CT. Clin Nucl Med. 2020;45(4):310\u20131.","journal-title":"Clin Nucl Med"},{"key":"1673_CR27","doi-asserted-by":"crossref","unstructured":"Zhou Y, He J, Chen Y. (68)Ga-FAPI PET\/CT imaging in a patient with thyroiditis. Endocrine. 2021;73(2):485\u2013486. (online ahead of print)","DOI":"10.1007\/s12020-021-02605-4"},{"issue":"4","key":"1673_CR28","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1007\/s00259-020-05028-x","volume":"48","author":"T Xu","year":"2021","unstructured":"Xu T, Zhao Y, Ding H, Cai L, Zhou Z, Song Z, et al. [(68)Ga]Ga-DOTA-FAPI-04 PET\/CT imaging in a case of prostate cancer with shoulder arthritis. Eur J Nucl Med Mol Imaging. 2021;48(4):1254\u20135.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"1673_CR29","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1007\/s00259-019-04623-x","volume":"47","author":"F Khreish","year":"2020","unstructured":"Khreish F, Rosar F, Kratochwil C, Giesel FL, Haberkorn U, Ezziddin S. Positive FAPI-PET\/CT in a metastatic castration-resistant prostate cancer patient with PSMA-negative\/FDG-positive disease. Eur J Nucl Med Mol Imaging. 2020;47(8):2040\u20131.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"1673_CR30","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.2174\/156652412803833607","volume":"12","author":"M Jacob","year":"2012","unstructured":"Jacob M, Chang L, Pur\u00e9 E. Fibroblast activation protein in remodeling tissues. Curr Mol Med. 2012;12(10):1220\u201343.","journal-title":"Curr Mol Med"},{"issue":"2","key":"1673_CR31","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00259-020-04941-5","volume":"48","author":"B Hao","year":"2021","unstructured":"Hao B, Wu X, Pang Y, Sun L, Wu H, Huang W, et al. [(18)F]FDG and ([68)Ga]Ga-DOTA-FAPI-04 PET\/CT in the evaluation of tuberculous lesions. Eur J Nucl Med Mol Imaging. 2021;48(2):651\u20132.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"1673_CR32","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1097\/RLU.0000000000003279","volume":"45","author":"B Gu","year":"2020","unstructured":"Gu B, Luo Z, He X, Wang J, Song S. 68Ga-FAPI and 18F-FDG PET\/CT images in a patient with extrapulmonary tuberculosis mimicking malignant tumor. Clin Nucl Med. 2020;45(11):865\u20137.","journal-title":"Clin Nucl Med"},{"issue":"1","key":"1673_CR33","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4251\/wjgo.v13.i1.87","volume":"13","author":"ML Caparelli","year":"2021","unstructured":"Caparelli ML, Batey JC, Tailor A, Braverman T, Barrat C. Internal hemorrhoid harboring adenocarcinoma: a case report. World J Gastrointest Oncol. 2021;13(1):87\u201391.","journal-title":"World J Gastrointest Oncol"},{"issue":"6","key":"1673_CR34","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1002\/hep.510290631","volume":"29","author":"MT Levy","year":"1999","unstructured":"Levy MT, McCaughan GW, Abbott CA, Park JE, Cunningham AM, M\u00fcller E, et al. Fibroblast activation protein: a cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis. Hepatology. 1999;29(6):1768\u201378.","journal-title":"Hepatology"},{"issue":"2","key":"1673_CR35","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1034\/j.1600-0676.2002.01503.x","volume":"22","author":"MT Levy","year":"2002","unstructured":"Levy MT, McCaughan GW, Marinos G, Gorrell MD. Intrahepatic expression of the hepatic stellate cell marker fibroblast activation protein correlates with the degree of fibrosis in hepatitis C virus infection. Liver. 2002;22(2):93\u2013101.","journal-title":"Liver"},{"issue":"10","key":"1673_CR36","doi-asserted-by":"publisher","first-page":"e430","DOI":"10.1097\/RLU.0000000000003015","volume":"45","author":"L Zhao","year":"2020","unstructured":"Zhao L, Gu J, Fu K, Lin Q, Chen H. 68Ga-FAPI PET\/CT in assessment of liver nodules in a cirrhotic patient. Clin Nucl Med. 2020;45(10):e430\u20132.","journal-title":"Clin Nucl Med"},{"issue":"12","key":"1673_CR37","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1097\/RLU.0000000000003345","volume":"45","author":"C Qin","year":"2020","unstructured":"Qin C, Gai Y, Liu Q, Shao F, Lan X. Elevated 68Ga-FAPI accumulation in a recurrent angiomyolipoma. Clin Nucl Med. 2020;45(12):1034\u20135.","journal-title":"Clin Nucl Med"},{"key":"1673_CR38","doi-asserted-by":"publisher","unstructured":"Giesel FL, Kratochwil C, Schlittenhardt J, Dendl K, Eiber M, Staudinger F, et al. Head-to-head intra-individual comparison of biodistribution and tumor uptake of (68)Ga-FAPI and (18)F-FDG PET\/CT in cancer patients. Eur J Nucl Med Mol Imaging. 2021 Jun 17.https:\/\/doi.org\/10.1007\/s00259-021-05307-1.. (online ahead of print).","DOI":"10.1007\/s00259-021-05307-1."},{"issue":"2","key":"1673_CR39","doi-asserted-by":"publisher","first-page":"160","DOI":"10.2967\/jnumed.120.244806","volume":"62","author":"A Altmann","year":"2021","unstructured":"Altmann A, Haberkorn U, Siveke J. The latest developments in imaging of fibroblast activation protein. J Nucl Med. 2021;62(2):160\u20137.","journal-title":"J Nucl Med"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-021-01673-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-021-01673-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-021-01673-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,30]],"date-time":"2021-10-30T08:10:21Z","timestamp":1635581421000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-021-01673-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,23]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1673"],"URL":"https:\/\/doi.org\/10.1007\/s12149-021-01673-w","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,23]]},"assertion":[{"value":"29 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the institutional review board of our hospital and written informed consent for publication of this report was obtained from the patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}